This inventor holds 2 USPTO granted patents and 7 published patent applications. Top assignee: University of Pennsylvania. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kalyani Nambiar: Innovator in AAV Capsid Technology
Introduction
Kalyani Nambiar is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of gene therapy through her innovative work on adeno-associated virus (AAV) capsids. With a total of 2 patents, her research is paving the way for advancements in therapeutic applications.
Latest Patents
Kalyani Nambiar's latest patents include "Novel AAV Capsids and Compositions Containing Same." This groundbreaking work focuses on the development of new AAV capsids that can enhance the delivery of genetic material for therapeutic purposes. Her contributions are vital in the ongoing quest to improve gene therapy techniques.
Career Highlights
Kalyani Nambiar is affiliated with the University of Pennsylvania, where she continues to push the boundaries of research in her field. Her work has garnered attention for its potential to revolutionize treatments for various genetic disorders.
Collaborations
Throughout her career, Kalyani has collaborated with esteemed colleagues such as James M. Wilson and Qiang Wang. These partnerships have enriched her research and expanded the impact of her innovations.
Conclusion
Kalyani Nambiar stands out as a leading inventor in the realm of AAV technology. Her patents and collaborations reflect her commitment to advancing gene therapy, making her a key figure in the scientific community.